|
E-mail this page to a friend!
Plans to Prevent Another Flu Vaccine Shortage:
Topic for Senate Aging Committee
Hearing Tuesday features FDA commissioner, CDC
official and others
Nov. 15, 2004 - The U.S. Senate Special Committee
on Aging will hold a hearing tomorrow featuring testimony by Lester M.
Crawford, Acting Commissioner of the Food and Drug Administration, about
the flu vaccine shortage and plans to prevent this happening next year.
Liability, Licensing and the Flu Vaccine Market:
Making Decisions Today to Prevent a Crisis Tomorrow, will be held in
room 628 of the Dirksen Senate Office Building in Washington, D.C.,
beginning at 2:30 p.m.
The hearing will center on the United States level
of preparedness for next year's flu season, contingency plans to address
another possible shortage in 2005, and a discussion of issues that must
be addressed in order to increase vaccine production in the United
States, according to Chairman Larry Craig.
In addition to an update from CDC and FDA, the
Aging Committee will hear business perspectives on the flu vaccine
market, including regulation, investment and manufacturing opportunities
and pitfalls.
According to the National Institute of Medicine, in
1967 there were 26 companies which manufactured flu vaccines for the
American market. This year there are only three companies which
manufactured flu vaccines for the U.S. and two of those companies are
located in England.
Tuesdays hearing will be webcast under the
Hearings section of the Aging Committees website and available for
viewing later at http://www.senate.gov.
Prepared witness testimony will be available on that website once the
hearing begins. An audiocast of the hearing may also be available
during the hearing only on the C-SPAN hearings website, located at
http://www.capitolhearings.org.
PANEL I:
Lester M. Crawford, D.V.M., Ph.D, Acting
Commissioner Food and Drug Administration, Rockville, MD
Mitchell L. Cohen, MD, Director, Coordinating
Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, GA
PANEL II:
Peter Paradiso, Ph.D., Vice President for New
Business & Scientific Affairs, Wyeth Pharmaceuticals, Collegeville, PA
Leighton Read, MD, Alloy Ventures, Palo Alto, CA
Frank A. Sloan, Ph.D., Center for Health Policy,
Law and Management, Terry Sanford Institute of Public Policy, Duke
University, Durham, NC
For more information, click here.
Click to More Senior News on the
Front Page
Copyright: SeniorJournal.com |
